• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cenduit’s launches upgraded Patient Reminders tool

Cenduit’s launches upgraded Patient Reminders tool

May 26, 2016
CenterWatch Staff

Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, has launched its upgraded Patient Reminders tool. Designed to improve patient compliance and engagement without placing additional burdens on sites or sponsors, the expanded features include a two-way messaging dashboard and a mobile app available for iOS and Android devices.

As a large IRT specialist, Cenduit is leveraging the company’s expertise in clinical domain to improve sponsor-patient interactions throughout the duration of the trial. Using personalized messaging to remind patients of any scheduled appointments and necessary preparations for their clinical visit, Patient Reminders effectively improves patient compliance and retention in clinical trials, saving sponsors on costs resulting from patient dropout and noncompliance. The tool can be easily integrated with existing Interactive Response Technology (IRT) systems or as a standalone service, simplifying patient communications throughout the trial. 

“Patient compliance is key to the success of any clinical trial. With our Patient Reminders tool, sponsors can have more control of their clinical trials and reduce patient dropout, which saves them time and money while increasing the quality of a trial’s endpoint data,” said Chris Dailey, global head of technology, Cenduit. “With new features, the upgraded tool gives sponsors a simple means to keep patients engaged in their trials by communicating in real time through the two-way messaging dashboard.”

The two-way messaging dashboard gives site users and sponsors a consolidated view of all interactions with patients. The dashboard allows for the monitoring of any reminders sent to patients, as well as their responses, to ensure the patients remain on track for any scheduled visits and medications.

Patients can also now send their responses to sponsors with an additional layer of security and privacy through the convenience of a mobile app, available for download on iOS and Android devices.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing